Rapid onset of action of orally administered C5aR Inhibitor CCX168 in randomized clinical trial in ANCA-associated vasculitis (CLEAR)
(2016) ASN Renal Week — Location: Chicago, IL (15.November.2018)
Files
Tesaretal.pdf
Closed Access - Adobe PDF
- 132.93 KB
Details
- Authors
- Affiliations
Citations
Tesar, V., Jayne, D. R., Bruchfeld, A., Harper, L., Schaier, M., Hamilton, P., Burst, V. R., Grundmann, F., Jadoul, M., Szombati, I., Potarca, A., Schall, T. J., & Bekker, P. (2016). Rapid onset of action of orally administered C5aR Inhibitor CCX168 in randomized clinical trial in ANCA-associated vasculitis (CLEAR). ASN Renal Week, Chicago, IL. https://hdl.handle.net/2078.5/57671